We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 17 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 30 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 08. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 05. 08. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 05. 07. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 04. 22. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 04. 15. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 04. 14. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 04. 10. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 02. 18. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 02. 17. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 02. 14. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 02. 13. | Oppenheimer | — | Upgrade | Perform → Outperform | — | Oppenheimer: Perform → Outperform |
| 2026. 02. 13. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 02. 12. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 01. 22. | Argus Research | — | Maintain | Buy → Buy | — | Argus Research: Buy |
| 2026. 01. 22. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 01. 13. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 11. 08. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 11. 07. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 10. 14. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2025. 10. 07. | Argus Research | — | Maintain | Buy → Buy | — | Argus Research: Buy |
| 2025. 10. 07. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 10. 07. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 10. 03. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2025. 09. 23. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 09. 08. | Wolfe Research | — | Upgrade | Underperform → Peer Perform | — | Wolfe Research: Underperform → Peer Perform |
| 2025. 08. 27. | Tigress Financial | — | Maintain | Buy → Buy | — | Tigress Financial: Buy |
| 2025. 08. 08. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 08. 07. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2025. 08. 07. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 06. 05. | Tigress Financial | — | Initiate coverage | — → Buy | — | Tigress Financial: Buy |
| 2025. 05. 14. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 05. 09. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 05. 08. | Baird | — | Maintain | Outperform → Outperform | — | Baird: Outperform |
| 2025. 05. 08. | Barclays | — | Upgrade | Equal-Weight → Overweight | — | Barclays: Equal-Weight → Overweight |
| 2025. 05. 07. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 04. 22. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 04. 16. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2025. 04. 14. | Barclays | — | Maintain | Equal-Weight → Equal-Weight | — | Barclays: Equal-Weight |
| 2025. 04. 11. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |